Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

46 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Reduction of HIV-1 RNA levels with therapy to suppress herpes simplex virus.
Nagot N, Ouédraogo A, Foulongne V, Konaté I, Weiss HA, Vergne L, Defer MC, Djagbaré D, Sanon A, Andonaba JB, Becquart P, Segondy M, Vallo R, Sawadogo A, Van de Perre P, Mayaud P; ANRS 1285 Study Group. Nagot N, et al. Among authors: vallo r. N Engl J Med. 2007 Feb 22;356(8):790-9. doi: 10.1056/NEJMoa062607. N Engl J Med. 2007. PMID: 17314338 Free article. Clinical Trial.
Longitudinal effect following initiation of highly active antiretroviral therapy on plasma and cervico-vaginal HIV-1 RNA among women in Burkina Faso.
Nagot N, Ouedraogo A, Weiss HA, Konate I, Sanon A, Defer MC, Sawadogo A, Andonaba JB, Vallo R, Becquart P, Segondy M, Mayaud P, Van de Perre P; Yerelon Study Group. Nagot N, et al. Among authors: vallo r. Sex Transm Infect. 2008 Jun;84(3):167-70. doi: 10.1136/sti.2007.027987. Epub 2007 Nov 30. Sex Transm Infect. 2008. PMID: 18055582
Roles of clinical and subclinical reactivated herpes simplex virus type 2 infection and human immunodeficiency virus type 1 (HIV-1)-induced immunosuppression on genital and plasma HIV-1 levels.
Nagot N, Ouedraogo A, Konate I, Weiss HA, Foulongne V, Defer MC, Sanon A, Becquart P, Segondy M, Sawadogo A, Van de Perre P, Mayaud P; ANRS 1285 Study Group. Nagot N, et al. J Infect Dis. 2008 Jul 15;198(2):241-9. doi: 10.1086/589621. J Infect Dis. 2008. PMID: 18593294 Clinical Trial.
Neisseria gonorrhoeae and Chlamydia trachomatis infection in HIV-1-infected women taking antiretroviral therapy: a prospective cohort study from Burkina Faso.
Low AJ, Konate I, Nagot N, Weiss HA, Mabey D, Segondy M, Vickerman P, Meda N, van de Perre P, Mayaud P; Yerelon Cohort study group. Low AJ, et al. Sex Transm Infect. 2014 Mar;90(2):100-3. doi: 10.1136/sextrans-2013-051233. Epub 2013 Dec 13. Sex Transm Infect. 2014. PMID: 24337732 Free PMC article.
Extended pre-exposure prophylaxis with lopinavir-ritonavir versus lamivudine to prevent HIV-1 transmission through breastfeeding up to 50 weeks in infants in Africa (ANRS 12174): a randomised controlled trial.
Nagot N, Kankasa C, Tumwine JK, Meda N, Hofmeyr GJ, Vallo R, Mwiya M, Kwagala M, Traore H, Sunday A, Singata M, Siuluta C, Some E, Rutagwera D, Neboua D, Ndeezi G, Jackson D, Maréchal V, Neveu D, Engebretsen IMS, Lombard C, Blanche S, Sommerfelt H, Rekacewicz C, Tylleskär T, Van de Perre P; ANRS 12174 Trial Group. Nagot N, et al. Among authors: vallo r. Lancet. 2016 Feb 6;387(10018):566-573. doi: 10.1016/S0140-6736(15)00984-8. Epub 2015 Nov 19. Lancet. 2016. PMID: 26603917 Clinical Trial.
46 results